Pacira Biosciences, Inc. (PCRX)

36.33 -0.07 (-0.19%) USD  |  NASDAQ  |  Oct 15, 16:00
36.60 +0.27 (+0.74%) Pre-Market: 08:16
More

Pacira Biosciences SG&A Expense (TTM) : 338.66M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 338.66M
March 31, 2026 334.59M
December 31, 2025 326.89M
September 30, 2025 305.75M
June 30, 2025 289.30M
March 31, 2025 271.38M
December 31, 2024 259.24M
September 30, 2024 245.88M
June 30, 2024 239.59M
March 31, 2024 237.37M
December 31, 2023 235.78M
September 30, 2023 233.08M
June 30, 2023 226.15M
March 31, 2023 225.56M
December 31, 2022 218.98M
September 30, 2022 207.97M
June 30, 2022 196.68M
March 31, 2022 183.37M
December 31, 2021 168.46M
September 30, 2021 169.55M
June 30, 2021 173.41M
March 31, 2021 167.03M
December 31, 2020 170.84M
September 30, 2020 180.32M
June 30, 2020 185.89M
Date Value
March 31, 2020 198.26M
December 31, 2019 202.00M
September 30, 2019 192.42M
June 30, 2019 186.47M
March 31, 2019 181.59M
December 31, 2018 177.27M
September 30, 2018 171.80M
June 30, 2018 168.26M
March 31, 2018 163.56M
December 31, 2017 161.49M
September 30, 2017 156.99M
June 30, 2017 152.66M
March 31, 2017 156.78M
December 31, 2016 152.61M
September 30, 2016 117.94M
June 30, 2016 116.94M
March 31, 2016 108.02M
December 31, 2015 101.49M
September 30, 2015 132.51M
June 30, 2015 125.42M
March 31, 2015 115.50M
December 31, 2014 106.66M
September 30, 2014 95.82M
June 30, 2014 82.92M
March 31, 2014 72.16M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Viatris, Inc. 3.981B
Johnson & Johnson 19.22B
Liquidia Corp. 192.66M
Organon & Co. 1.706B
ANI Pharmaceuticals, Inc. 324.76M